Ross Paveley
About Ross Paveley
Ross Paveley serves as the Head of Pharmacology at Exscientia in Oxford, United Kingdom, where he has worked since 2020. He has a diverse background in immunology and drug discovery, with previous roles at UCB, the University of York, and the London School of Hygiene and Tropical Medicine.
Work at Exscientia
Ross Paveley has served as the Head of Pharmacology at Exscientia since 2020. In this role, he leads the strategic planning and execution of innovative IT data capture and visualization platforms. His responsibilities include managing the development and deployment of assays for high-throughput and high-content screening. He specializes in creating complex multi-cellular models that mimic disease indications and has extensive experience in validating new technologies, including automation and machine learning imaging techniques.
Education and Expertise
Ross Paveley earned his PhD in Immunology from the University of York, where he studied from 2005 to 2009. He also holds an MSc in Medical Parasitology from the London School of Hygiene and Tropical Medicine, completed in 2004, and a BSc in Biological Sciences with Parasitology from King's College London, achieved in 2001. His educational background supports his expertise in pharmacology, particularly in drug discovery and the development of assays for screening.
Background
Before joining Exscientia, Ross Paveley held several significant positions in academia and industry. He worked as a Research Fellow at the London School of Hygiene and Tropical Medicine from 2009 to 2015, focusing on drug discovery for neglected tropical diseases. Prior to that, he was a Senior Scientist at UCB from 2015 to 2017 and a Principal Scientist/Group Leader at UCB from 2017 to 2020. His early career included roles as a PhD student and postgraduate researcher at the University of York.
Achievements
Ross Paveley has a proven track record in managing multiple small molecule and biological projects throughout various phases of drug discovery. He possesses expertise in managing Contract Research Organizations (CROs) and implementing automation and robotics in pharmacology projects. His work has contributed to the advancement of innovative methodologies in pharmacology and drug development.